Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats

Satoru Naruse, Youxue Wang, Motoji Kitagawa, Hiroshi Ishiguro, Yasunaga Seki, Tsuyoshi Ozaki, Tetsuo Hayakawa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Long-term effects of nafamostat mesylate, a protease inhibitor, and imipenem, an antibiotic, on trypsin-taurocholate-induced acute pancreatitis were studied in rats. Sham-operated rats infused with a buffer solution into the pancreatic duct served as controls. Nafamostat (1 mg/kg), imi-· penem (10 mg/kg), or imipenem + nafamostat in saline was injected subcutaneously 0.25, 3, 24, and 48 hours after the induction of pancreatitis. In untreated rats and control rats, saline was injected at the same intervals as in the treated rats. All rats in an untreated group died within 3.5 days (median survival, 1.25 day) after the induction of pancreatitis. The 2-week survival rate was significantly (p < 0.05) improved by a combination of nafamostat and imipenem (42%), but not by nafamostat (17%), or imipenem (8%) alone. Bacterial culture at 24 hours revealed infection of necrotic pancreatic tissues and ascites by intestinal bacteria in all untreated rats but not in control rats. Bacterial counts were significantly reduced by imipenem, but not by nafamostat. In conclusion, bacterial infection occurred within 24 hours after the induction of trypsin-taurocholate pancreatitis in rats. Early treatment with nafamostat + imipenem, but not nafamostat or imipenem alone, improves long-term survival.

Original languageEnglish (US)
Pages (from-to)290-295
Number of pages6
JournalPancreas
Volume21
Issue number3
DOIs
StatePublished - 2000

Fingerprint

Imipenem
Pancreatitis
Taurocholic Acid
meropenem
Trypsin
nafamostat
Bacterial Load
Pancreatic Ducts
Protease Inhibitors
Bacterial Infections
Ascites
Buffers
Anti-Bacterial Agents
Bacteria

Keywords

  • Acute necrotizing pancreatitis
  • Antibiotics
  • Bacterial infection
  • Protease inhibitor
  • Survival

ASJC Scopus subject areas

  • Gastroenterology
  • Endocrinology

Cite this

Naruse, S., Wang, Y., Kitagawa, M., Ishiguro, H., Seki, Y., Ozaki, T., & Hayakawa, T. (2000). Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. Pancreas, 21(3), 290-295. https://doi.org/10.1097/00006676-200010000-00011

Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. / Naruse, Satoru; Wang, Youxue; Kitagawa, Motoji; Ishiguro, Hiroshi; Seki, Yasunaga; Ozaki, Tsuyoshi; Hayakawa, Tetsuo.

In: Pancreas, Vol. 21, No. 3, 2000, p. 290-295.

Research output: Contribution to journalArticle

Naruse, S, Wang, Y, Kitagawa, M, Ishiguro, H, Seki, Y, Ozaki, T & Hayakawa, T 2000, 'Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats', Pancreas, vol. 21, no. 3, pp. 290-295. https://doi.org/10.1097/00006676-200010000-00011
Naruse, Satoru ; Wang, Youxue ; Kitagawa, Motoji ; Ishiguro, Hiroshi ; Seki, Yasunaga ; Ozaki, Tsuyoshi ; Hayakawa, Tetsuo. / Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. In: Pancreas. 2000 ; Vol. 21, No. 3. pp. 290-295.
@article{14714a154f804bf8b86063097c59be88,
title = "Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats",
abstract = "Long-term effects of nafamostat mesylate, a protease inhibitor, and imipenem, an antibiotic, on trypsin-taurocholate-induced acute pancreatitis were studied in rats. Sham-operated rats infused with a buffer solution into the pancreatic duct served as controls. Nafamostat (1 mg/kg), imi-· penem (10 mg/kg), or imipenem + nafamostat in saline was injected subcutaneously 0.25, 3, 24, and 48 hours after the induction of pancreatitis. In untreated rats and control rats, saline was injected at the same intervals as in the treated rats. All rats in an untreated group died within 3.5 days (median survival, 1.25 day) after the induction of pancreatitis. The 2-week survival rate was significantly (p < 0.05) improved by a combination of nafamostat and imipenem (42{\%}), but not by nafamostat (17{\%}), or imipenem (8{\%}) alone. Bacterial culture at 24 hours revealed infection of necrotic pancreatic tissues and ascites by intestinal bacteria in all untreated rats but not in control rats. Bacterial counts were significantly reduced by imipenem, but not by nafamostat. In conclusion, bacterial infection occurred within 24 hours after the induction of trypsin-taurocholate pancreatitis in rats. Early treatment with nafamostat + imipenem, but not nafamostat or imipenem alone, improves long-term survival.",
keywords = "Acute necrotizing pancreatitis, Antibiotics, Bacterial infection, Protease inhibitor, Survival",
author = "Satoru Naruse and Youxue Wang and Motoji Kitagawa and Hiroshi Ishiguro and Yasunaga Seki and Tsuyoshi Ozaki and Tetsuo Hayakawa",
year = "2000",
doi = "10.1097/00006676-200010000-00011",
language = "English (US)",
volume = "21",
pages = "290--295",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats

AU - Naruse, Satoru

AU - Wang, Youxue

AU - Kitagawa, Motoji

AU - Ishiguro, Hiroshi

AU - Seki, Yasunaga

AU - Ozaki, Tsuyoshi

AU - Hayakawa, Tetsuo

PY - 2000

Y1 - 2000

N2 - Long-term effects of nafamostat mesylate, a protease inhibitor, and imipenem, an antibiotic, on trypsin-taurocholate-induced acute pancreatitis were studied in rats. Sham-operated rats infused with a buffer solution into the pancreatic duct served as controls. Nafamostat (1 mg/kg), imi-· penem (10 mg/kg), or imipenem + nafamostat in saline was injected subcutaneously 0.25, 3, 24, and 48 hours after the induction of pancreatitis. In untreated rats and control rats, saline was injected at the same intervals as in the treated rats. All rats in an untreated group died within 3.5 days (median survival, 1.25 day) after the induction of pancreatitis. The 2-week survival rate was significantly (p < 0.05) improved by a combination of nafamostat and imipenem (42%), but not by nafamostat (17%), or imipenem (8%) alone. Bacterial culture at 24 hours revealed infection of necrotic pancreatic tissues and ascites by intestinal bacteria in all untreated rats but not in control rats. Bacterial counts were significantly reduced by imipenem, but not by nafamostat. In conclusion, bacterial infection occurred within 24 hours after the induction of trypsin-taurocholate pancreatitis in rats. Early treatment with nafamostat + imipenem, but not nafamostat or imipenem alone, improves long-term survival.

AB - Long-term effects of nafamostat mesylate, a protease inhibitor, and imipenem, an antibiotic, on trypsin-taurocholate-induced acute pancreatitis were studied in rats. Sham-operated rats infused with a buffer solution into the pancreatic duct served as controls. Nafamostat (1 mg/kg), imi-· penem (10 mg/kg), or imipenem + nafamostat in saline was injected subcutaneously 0.25, 3, 24, and 48 hours after the induction of pancreatitis. In untreated rats and control rats, saline was injected at the same intervals as in the treated rats. All rats in an untreated group died within 3.5 days (median survival, 1.25 day) after the induction of pancreatitis. The 2-week survival rate was significantly (p < 0.05) improved by a combination of nafamostat and imipenem (42%), but not by nafamostat (17%), or imipenem (8%) alone. Bacterial culture at 24 hours revealed infection of necrotic pancreatic tissues and ascites by intestinal bacteria in all untreated rats but not in control rats. Bacterial counts were significantly reduced by imipenem, but not by nafamostat. In conclusion, bacterial infection occurred within 24 hours after the induction of trypsin-taurocholate pancreatitis in rats. Early treatment with nafamostat + imipenem, but not nafamostat or imipenem alone, improves long-term survival.

KW - Acute necrotizing pancreatitis

KW - Antibiotics

KW - Bacterial infection

KW - Protease inhibitor

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0033807063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033807063&partnerID=8YFLogxK

U2 - 10.1097/00006676-200010000-00011

DO - 10.1097/00006676-200010000-00011

M3 - Article

C2 - 11039474

AN - SCOPUS:0033807063

VL - 21

SP - 290

EP - 295

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 3

ER -